methyl-3-(3-oxobenzo[d]isothiazol-2(3H)-yl)benzoate | 1135317-63-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl-3-(3-oxobenzo[d]isothiazol-2(3H)-yl)benzoate
• 英文别名: Methyl 3-(3-oxo-1,2-benzothiazol-2-yl)benzoate
• CAS: 1135317-63-3
• 化学式: C₁₅H₁₁NO₃S
• 分子量: 285.323
• InChiKey: YZRVQRVLCVYTKC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  71.9
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl-3-(3-oxobenzo[d]isothiazol-2(3H)-yl)benzoate 在 lithium hydroxide monohydrate 作用下， 以 四氢呋喃 、 甲醇 、 水 为溶剂， 反应 40.0h， 以71%的产率得到3-(3-oxobenzo[d]isothiazol-2(3H)-yl)benzoic acid
  参考文献：
  名称：

  评估取代的依布硒啉衍生物作为潜在的锥虫杀虫剂

  摘要：

  人类非洲锥虫病是撒哈拉以南非洲地区的一种疾病，成千上万的人有患这种疾病的危险。该疾病通常称为非洲昏睡病，是由真核病原体布鲁氏锥虫感染引起的。以前，基于目标的高通量筛选揭示依布硒啉（EbSe），和它的硫类似物，EBS，是有效的体外的抑制剂锥虫己糖激酶1（TbHK1）。这些分子在体内也表现出强大的杀锥虫活性。在这份手稿中，我们合成了一系列的十六种EbSe和EbS具有吸电子羧酸和甲基酯官能团的衍生物，并评估了这些取代基对母体支架的生物学功效的影响。除一种甲酯衍生物外，这些修饰消除或减弱了对母体支架的有效TbHK1抑制作用。然而，一些甲基酯衍生物仍表现出锥虫杀伤作用，其单位数微摩尔或高纳摩尔EC 50值。

  DOI：

  10.1016/j.bmcl.2016.12.021
• 作为产物：
  描述：

  2-碘苯甲酸 在 copper(l) iodide 、 氯化亚砜 、 1,10-菲罗啉 、 potassium carbonate 、 sulfur 、 三乙胺 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 0.5h， 生成 methyl-3-(3-oxobenzo[d]isothiazol-2(3H)-yl)benzoate
  参考文献：
  名称：

  评估取代的依布硒啉衍生物作为潜在的锥虫杀虫剂

  摘要：

  人类非洲锥虫病是撒哈拉以南非洲地区的一种疾病，成千上万的人有患这种疾病的危险。该疾病通常称为非洲昏睡病，是由真核病原体布鲁氏锥虫感染引起的。以前，基于目标的高通量筛选揭示依布硒啉（EbSe），和它的硫类似物，EBS，是有效的体外的抑制剂锥虫己糖激酶1（TbHK1）。这些分子在体内也表现出强大的杀锥虫活性。在这份手稿中，我们合成了一系列的十六种EbSe和EbS具有吸电子羧酸和甲基酯官能团的衍生物，并评估了这些取代基对母体支架的生物学功效的影响。除一种甲酯衍生物外，这些修饰消除或减弱了对母体支架的有效TbHK1抑制作用。然而，一些甲基酯衍生物仍表现出锥虫杀伤作用，其单位数微摩尔或高纳摩尔EC 50值。

  DOI：

  10.1016/j.bmcl.2016.12.021

文献信息

• Design, synthesis and evaluation of benzoisothiazolones as selective inhibitors of PHOSPHO1
  作者：Yalda Bravo、Peter Teriete、Raveendra-Panickar Dhanya、Russell Dahl、Pooi San Lee、Tina Kiffer-Moreira、Santhi Reddy Ganji、Eduard Sergienko、Layton H. Smith、Colin Farquharson、José Luis Millán、Nicholas D.P. Cosford

  DOI：10.1016/j.bmcl.2014.07.013

  日期：2014.9

  We report the discovery and characterization of a series of benzoisothiazolone inhibitors of PHOSPHO1, a newly identified soluble phosphatase implicated in skeletal mineralization and soft tissue ossification abnormalities. High-throughput screening (HTS) of a small molecule library led to the identification of benzoisothiazolones as potent and selective inhibitors of PHOSPHO1. Critical structural requirements for activity were determined, and the compounds were subsequently derivatized and measured for in vitro activity and ADME parameters including metabolic stability and permeability. On the basis of its overall profile the benzoisothiazolone analogue 2q was selected as MLPCN probe ML086.
• BENZOISOTHIAZOLONES AS INHIBITORS OF PHOSPHOMANNOSE ISOMERASE
  申请人：Cosford Nicholas D. P.

  公开号：US20110257233A1

  公开（公告）日：2011-10-20

  The disclosure provides new compounds and compositions thereof, and methods for treating or ameliorating a disorder relating to CDG-Ia. In particular, the disclosure provides benzoisothiazolone inhibitors of PMI, which have been synthesized and their ability to drive glycosylation has been demonstrated. The disclosure provides two synthetic routes for these compounds, including a new copper-catalyzed N-arylation reaction amenable to parallel derivitization. The disclosed compounds represent potent inhibitors of PMI, and their dose-dependent efficacy in cell-based models of glycosylation have been demonstrated. In addition, the disclosed compounds are selective over PMM and therefore, are useful in treating or ameliorating a disorder relating to CDG-Ia.
• TREATMENT OF MALARIA USING INHIBITORS OF THE ISPD ENZYME IN THE NON-MEVALONATE PATHWAY
  申请人：Washington University

  公开号：US20160046651A1

  公开（公告）日：2016-02-18

  Compounds are disclosed that inhibit the methylerythritol cytidyltransferase (IspD) enzyme in the non-mevalonate pathway (MEP pathway), which is present in many organisms including the P. falciparum parasite. Inhibitors of the IspD enzyme in the non-mevalonate pathway of the P. falciparum parasite are useful for treating malaria.
• [EN] BENZOISOTHIAZOLONES AS INHIBITORS OF PHOSPHOMANNOSE ISOMERASE<br/>[FR] BENZOISOTHIAZOLONES EN TANT QU'INHIBITEURS DE PHOSPHOMANNOSE ISOMÉRASE (PMI)
  申请人：SANFORD BURNHAM MED RES INST

  公开号：WO2011116355A2

  公开（公告）日：2011-09-22

  The disclosure provides new compounds and compositions thereof, and methods for treating or ameliorating a disorder relating to CDG-Ia. In particular, the disclosure provides benzoisothiazolone inhibitors of PMI, which have been synthesized and their ability to drive glycosylation has been demonstrated. The disclosure provides two synthetic routes for these compounds, including a new copper-catalyzed N-arylation reaction amenable to parallel derivitization. The disclosed compounds represent potent inhibitors of PMI, and their dose- dependent efficacy in cell-based models of glycosylation have been demonstrated. In addition, the disclosed compounds are selective over PMM and therefore, are useful in treating or ameliorating a disorder relating to CDG-Ia.
• Evaluation of substituted ebselen derivatives as potential trypanocidal agents
  作者：Heeren M. Gordhan、Stephen L. Patrick、Maria I. Swasy、Amber L. Hackler、Mark Anayee、Jennifer E. Golden、James C. Morris、Daniel C. Whitehead

  DOI：10.1016/j.bmcl.2016.12.021

  日期：2017.2

  Human African trypanosomiasis is a disease of sub-Saharan Africa, where millions are at risk for the illness. The disease, commonly referred to as African sleeping sickness, is caused by an infection by the eukaryotic pathogen, Trypanosoma brucei. Previously, a target-based high throughput screen revealed ebselen (EbSe), and its sulfur analog, EbS, to be potent in vitro inhibitors of the T. brucei

  人类非洲锥虫病是撒哈拉以南非洲地区的一种疾病，成千上万的人有患这种疾病的危险。该疾病通常称为非洲昏睡病，是由真核病原体布鲁氏锥虫感染引起的。以前，基于目标的高通量筛选揭示依布硒啉（EbSe），和它的硫类似物，EBS，是有效的体外的抑制剂锥虫己糖激酶1（TbHK1）。这些分子在体内也表现出强大的杀锥虫活性。在这份手稿中，我们合成了一系列的十六种EbSe和EbS具有吸电子羧酸和甲基酯官能团的衍生物，并评估了这些取代基对母体支架的生物学功效的影响。除一种甲酯衍生物外，这些修饰消除或减弱了对母体支架的有效TbHK1抑制作用。然而，一些甲基酯衍生物仍表现出锥虫杀伤作用，其单位数微摩尔或高纳摩尔EC 50值。